0.16Open0.16Pre Close0 Volume11 Open Interest67.00Strike Price0.00Turnover4841.89%IV13.41%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.16Extrinsic Value100Contract SizeAmericanOptions Type-0.0528Delta0.0155Gamma482.44Leverage Ratio-284.8505Theta0.0000Rho-25.46Eff Leverage0.0002Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet